Automatic Thoughts, Self-Stigma, and Resilience Among Schizophrenia Patients with Metabolic Syndrome: A Cross-Sectional Study

References

• North HF, Weissleder C, Fullerton JM, Sager R, Webster MJ, Weickert CS. A schizophrenia subgroup with elevated inflammation displays reduced microglia, increased peripheral immune cell and altered neurogenesis marker gene expression in the subependymal zone. Transl Psychiatry. 2021;11(1):635. doi:10.1038/s41398-021-01742-8
   PubMed Web of Science ®Google Scholar
• Sahpolat M, Ari M. Higher prevalence of metabolic syndrome and related factors in patients with first-episode psychosis and schizophrenia: a cross-sectional study in Turkey. Nord J Psychiatry. 2021;75(1):73–78. doi:10.1080/08039488.2020.1815080
   PubMed Web of Science ®Google Scholar
• Penninx B, Lange SMM. Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications. Dialogues Clin Neurosci. 2018;20(1):63–73. doi:10.31887/DCNS.2018.20.1/bpenninx
   PubMed Web of Science ®Google Scholar
• Ringen PA, Engh JA, Birkenaes AB, Dieset I, Andreassen OA. Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions. Front Psychiatry. 2014;5:137. doi:10.3389/fpsyt.2014.00137
   PubMed Web of Science ®Google Scholar
• Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2(5–6):231–237. doi:10.1242/dmm.001180
   PubMed Web of Science ®Google Scholar
• Laursen TM, Munk-Olsen T, Vestergaard M. Life expectancy and cardiovascular mortality in persons with schizophrenia. Curr Opin Psychiatry. 2012;25(2):83–88. doi:10.1097/YCO.0b013e32835035ca
   PubMed Web of Science ®Google Scholar
• Ijaz S, Blanca B, Davies S, et al. Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews. Focus. 2020;18(4):482–492. doi:10.1176/appi.focus.18307
   PubMedGoogle Scholar
• Thakore JH, Mann JN, Vlahos I, Martin A, Reznek R. Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia. Int J Obes Related Metabol Disord. 2002;26(1):137–141. doi:10.1038/sj.ijo.0801840
   PubMed Web of Science ®Google Scholar
• Lin P, Sun J, Lou X, et al. Consensus on potential biomarkers developed for use in clinical tests for schizophrenia. General Psychiatry. 2022;35(1):e100685. doi:10.1136/gpsych-2021-100685
   PubMed Web of Science ®Google Scholar
• Sun MJ, Jang MH. Risk factors of metabolic syndrome in community-dwelling people with schizophrenia. Int J Environ Res Public Health. 2020;17(18):6700. doi:10.3390/ijerph17186700
   PubMed Web of Science ®Google Scholar
• Sugawara N, Yasui-Furukori N, Yamazaki M, et al. Attitudes toward metabolic adverse events among patients with schizophrenia in Japan. Neuropsychiatr Dis Treat. 2016;12:427–436. doi:10.2147/NDT.S98711
   PubMed Web of Science ®Google Scholar
• Dai J, Du X, Yin G, et al. Prevalence, demographic and clinical features of comorbid depressive symptoms in drug naive patients with schizophrenia presenting with first episode psychosis. Schizophr Res. 2018;193:182–187. doi:10.1016/j.schres.2017.06.029
   PubMed Web of Science ®Google Scholar
• Gross J, Vancampfort D, Stubbs B, Gorczynski P, Soundy A. A narrative synthesis investigating the use and value of social support to promote physical activity among individuals with schizophrenia. Disabil Rehabil. 2016;38(2):123–150. doi:10.3109/09638288.2015.1024343
   PubMed Web of Science ®Google Scholar
• Sun L, Xu M, Shi Y, Xu Y, Chen J, He L. Decoding psychosis: from national genome project to national brain project. General Psychiatry. 2022;35(4):e100889. doi:10.1136/gpsych-2022-100889
   PubMed Web of Science ®Google Scholar
• Komatsu H, Ono T, Onoguchi G, Tomita H, Kakuto Y. Mediating effects of self-stigma and depression on the association between autistic symptoms and recovery in patients with schizophrenia-spectrum disorders: a cross-sectional study. BMC Psychiatry. 2021;21(1):464. doi:10.1186/s12888-021-03472-z
   PubMed Web of Science ®Google Scholar
• Küçükkubaş N, Korkusuz F. What happens to bone mineral density, strength and body composition of ex-elite female volleyball players: a cross sectional study. Sci Sports. 2019;34(4):e259–e269. (). doi:10.1016/j.scispo.2018.11.006
   Web of Science ®Google Scholar
• Ivezić S, Sesar MA, Mužinić L. Effects of a group psychoeducation program on self-stigma, empowerment and perceived discrimination of persons with schizophrenia. Psychiatr Danub. 2017;29(1):66–73. doi:10.24869/psyd.2017.66
   PubMed Web of Science ®Google Scholar
• Zhang X, He C, Ju P, et al. The predictive role of aberrant metabolic parameters and negative automatic thinking on the cognitive impairments among schizophrenia patients with metabolic syndrome. Neuropsychiatr Dis Treat. 2022;18:1087–1097. doi:10.2147/NDT.S367392
   PubMed Web of Science ®Google Scholar
• Popa CO, Rus AV, Lee WC, et al. The relation between negative automatic thoughts and psychological inflexibility in schizophrenia. J Clin Med. 2022;11(3):871. doi:10.3390/jcm11030871
   PubMed Web of Science ®Google Scholar
• Valery KM, Prouteau A. Schizophrenia stigma in mental health professionals and associated factors: a systematic review. Psychiatry Res. 2020;290:113068. doi:10.1016/j.psychres.2020.113068
   PubMed Web of Science ®Google Scholar
• Mizuno Y, Hofer A, Frajo-Apor B, et al. Religiosity and psychological resilience in patients with schizophrenia and bipolar disorder: an international cross-sectional study. Acta Psychiatr Scand. 2018;137(4):316–327. doi:10.1111/acps.12838
   PubMed Web of Science ®Google Scholar
• Takeda T, Nakataki M, Ohta M, et al. Negative and positive self-thoughts predict subjective quality of life in people with schizophrenia. Neuropsychiatr Dis Treat. 2019;15:293–301. doi:10.2147/NDT.S190381
   PubMed Web of Science ®Google Scholar
• Bozikas VP, Parlapani E, Holeva V, et al. Resilience in patients with recent diagnosis of a schizophrenia spectrum disorder. J Nerv Ment Dis. 2016;204(8):578–584. doi:10.1097/NMD.0000000000000541
   PubMed Web of Science ®Google Scholar
• Senormanci G, Guclu O, Senormanci O. Resilience and associated factors in schizophrenia. Turk Psikiyatri Derg. 2022;33(1):1–10. doi:10.5080/u25738
   PubMed Web of Science ®Google Scholar
• Demir A, Manolya A, Küçükkubaş N. Comparison of dynamic balance properties of hypermobility in boys. Int J Sport Exer Train Sci. 2019;5(1):15–22. doi:10.18826/useeabd.510426
   Google Scholar
• Hofer A, Mizuno Y, Frajo-Apor B, et al. Resilience, internalized stigma, self-esteem, and hopelessness among people with schizophrenia: cultural comparison in Austria and Japan. Schizophr Res. 2016;171(1–3):86–91. doi:10.1016/j.schres.2016.01.027
   PubMed Web of Science ®Google Scholar
• First MB. Diagnostic and statistical manual of mental disorders, 5th edition, and clinical utility. J Nerv Ment Dis. 2013;201(9):727–729. doi:10.1097/NMD.0b013e3182a2168a
   PubMed Web of Science ®Google Scholar
• Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults. [Chinese guidelines on prevention and treatment of dyslipidemia in adults]. Zhonghua xin xue guan bing za zhi. 2007;35(5):390–419. Chinese.
   PubMedGoogle Scholar
• Haig GM, Wang D, Zhao J, Othman AA, Bain EE. Efficacy and safety of the α7-nicotinic acetylcholine receptor agonist ABT-126 in the treatment of cognitive impairment associated with schizophrenia: results from a Phase 2b randomized controlled study in smokers. J Clin Psychiatry. 2018;79(3). doi:10.4088/JCP.16m11162
   PubMed Web of Science ®Google Scholar
• Si T-M, Shu L, Dang W-M, et al. Evaluation of the reliability and validity of Chinese version of the Mini-International Neuropsychiatric Interview in patients with mental disorders. Chin Mental Health J. 2009;23:493–503.
   Google Scholar
• Wu BJ, Lan TH, Hu TM, Lee SM, Liou JY. Validation of a five-factor model of a Chinese Mandarin version of the Positive and Negative Syndrome Scale (CMV-PANSS) in a sample of 813 schizophrenia patients. Schizophr Res. 2015;169(1–3):489–490. doi:10.1016/j.schres.2015.09.011
   PubMed Web of Science ®Google Scholar
• Li J, Oakley LD, Brown RL, Li Y, Luo Y. Properties of the early symptom measurement of post-stroke depression: concurrent criterion validity and cutoff scores. J Nurs Res. 2020;28(4):e107. doi:10.1097/jnr.0000000000000380
   PubMedGoogle Scholar
• Wong DF, Chau P, Kwok A, Kwan J. Cognitive-behavioral treatment groups for people with chronic physical illness in Hong Kong: reflections on a culturally attuned model. Int J Group Psychother. 2007;57(3):367–385. doi:10.1111/ppc.12994
   PubMed Web of Science ®Google Scholar
• Corrigan PW, Mittal D, Reaves CM, et al. Mental health stigma and primary health care decisions. Psychiatry Res. 2014;218(1–2):35–38. doi:10.1016/j.psychres.2014.04.028
   PubMed Web of Science ®Google Scholar
• Boyd JE, Adler EP, Otilingam PG, Peters T. Internalized Stigma of Mental Illness (ISMI) scale: a multinational review. Compr Psychiatry. 2014;55(1):221–231. doi:10.1016/j.comppsych.2013.06.005
   PubMed Web of Science ®Google Scholar
• Connor KM, Davidson JR. Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety. 2003;18(2):76–82. doi:10.1002/da.10113
   PubMed Web of Science ®Google Scholar
• Mitchell AJ, Vancampfort D, Sweers K, van Winkel R, Yu W, De Hert M. Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis. Schizophr Bull. 2013;39(2):306–318. doi:10.1093/schbul/sbr148
   PubMed Web of Science ®Google Scholar
• Malhotra N, Grover S, Chakrabarti S, Kulhara P. Metabolic syndrome in schizophrenia. Indian J Psychol Med. 2013;35(3):227–240. doi:10.4103/0253-7176.119471
   PubMedGoogle Scholar
• Sahpolat M, Ari M, Kokacya MH. Plasma apelin, visfatin and resistin levels in patients with first episode psychosis and chronic schizophrenia. Clin Psychopharmacol Neurosci. 2020;18(1):109. doi:10.9758/cpn.2020.18.1.109
   PubMed Web of Science ®Google Scholar
• Yaprak Y, Küçükkubaş N. Gender-related differences on physical fitness parameters after core training exercises: a comparative study. Progress Nutr. 2020;22(3):e2020028.
   Web of Science ®Google Scholar
• Küçükkubaş N, Günay A, Löklüoğlu B, Kakil B. Relationship between body composition, vertical jump, 30 M sprint, static strength and anaerobic power for athletes. Int J Sport Exer Train Sci. 2019;5(2):68–78. doi:10.18826/useeabd.517037
   Google Scholar
• Malan-Muller S, Kilian S, van den Heuvel LL, et al. A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia. Schizophr Res. 2016;170(1):1–17. doi:10.1016/j.schres.2015.11.011
   PubMed Web of Science ®Google Scholar
• Carney R, Cotter J, Bradshaw T, Firth J, Yung AR. Cardiometabolic risk factors in young people at ultra-high risk for psychosis: a systematic review and meta-analysis. Schizophr Res. 2016;170(2–3):290–300. doi:10.1016/j.schres.2016.01.010
   PubMed Web of Science ®Google Scholar
• Emul M, Kalelioglu T. Etiology of cardiovascular disease in patients with schizophrenia: current perspectives. Neuropsychiatr Dis Treat. 2015;11:2493–2503. doi:10.2147/NDT.S50006
   PubMed Web of Science ®Google Scholar
• Liu J, Fu L. Metabolic syndrome in patients with schizophrenia: why should we care. Medicine. 2022;101(32):e29775. doi:10.1097/MD.0000000000029775
   PubMed Web of Science ®Google Scholar
• Hasnain M, Fredrickson SK, Vieweg WV, Pandurangi AK. Metabolic syndrome associated with schizophrenia and atypical antipsychotics. Curr Diab Rep. 2010;10(3):209–216. doi:10.1007/s11892-010-0112-8
   PubMed Web of Science ®Google Scholar
• Brohan E, Slade M, Clement S, Thornicroft G. Experiences of mental illness stigma, prejudice and discrimination: a review of measures. BMC Health Serv Res. 2010;10:80. doi:10.1186/1472-6963-10-80
   PubMed Web of Science ®Google Scholar
• Mosanya TJ, Adelufosi AO, Adebowale OT, Ogunwale A, Adebayo OK. Self-stigma, quality of life and schizophrenia: an outpatient clinic survey in Nigeria. Int J Soc Psychiatry. 2014;60(4):377–386. doi:10.1177/0020764013491738
   PubMed Web of Science ®Google Scholar
• Sevi O, Eylen Özyurt B. OTOMATİK DÜŞÜNCELER ÖLÇEĞİ’NİN ŞİZOFRENİ HASTALARININ OLUMSUZ OTOMATİK DÜŞÜNCELERİNİ DEĞERLENDİRMEDE GEÇERLİK VE GÜVENİRLİĞİNE DAİR BİR ÖN ÇALIŞMA [A pilot study of the reliability and validity of automatic thoughts questionnaire in assesment of schizophphrenic patient’s automatic thoughts]. Anatol J Clin Invest. 2013;7:1–9.
   Google Scholar
• Sahin AO, Ozer D, Bulut R, Sahin F. Investigation of the relationship between the negative automatic thoughts of patients with schizophrenia and their levels of social functionality. Perspect Psychiatr Care. 2022;58(4):1819–1825.
   PubMed Web of Science ®Google Scholar
• Sahpolat M, Ayar D, Ari M, Karaman MA. Elevated monocyte to high-density lipoprotein ratios as an inflammation markers for schizophrenia patients. Clin Psychopharmacol Neurosci. 2021;19(1):112. doi:10.9758/cpn.2021.19.1.112
   PubMed Web of Science ®Google Scholar